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ABSTRACT
Background: Current trends in clinical dental implant therapy include modification of titanium surfaces for the purpose of
improving osseointegration by different additive (bioactive coatings) and subtractive processes (acid etching, grit-blasting).
The aim of this study was to evaluate and compare the behaviour of hydroxyapatite and the newly developed bioactive glass
coated implants (62 implants) in osseous tissue following implantation in 31 patients.
Methods: Bioactive glass and hydroxyapatite was suitably coated on titanium alloy. Hydroxyapatite coating was applied on
the implant surface by air microplasma spray technique and bioactive glass coating was applied by vitreous enamelling
technique. The outcome was assessed up to 12 months after prosthetic loading using different clinical and radiological
parameters.
Results: Hydroxyapatite and bioactive glass coating materials were non-toxic and biocompatible. Overall results showed
that bioactive glass coated implants were as equally successful as hydroxyapatite in achieving osseointegration and
supporting final restorations.
Conclusions: The newly developed bioactive glass is a good alternative coating material for dental implants.
Keywords: Bioactive glass, biocompatible, coated implants, hydroxyapatite, osseointegration.
Abbreviations and acronyms: ABL = average marginal bone loss; BG = bioactive glass; GI = gingival index; GR = gingival recession; HA =
hydroxyapatite; IFG = interfacial; IOPA = intraoral periapical; MDCT = multi-detector spiral CT scan; PI = plaque index; PPD = probing
pocket depth.
(Accepted for publication 18 July 2010.)
INTRODUCTION
Endosseous dental implants have been used in dentistry
for many years to improve the appearance and func-
tional ability of the natural dentition.1 As bio-inert
materials often become encapsulated in fibrous tissue, it
is important to develop new biomaterials to ensure the
extended lifetime of implants.2 Bioactive materials such
as hydroxyapatite (HA) and bioactive glass (BG) can
develop a chemical bond with the bone that is stronger
than either the bone or ceramic alone.3,4 There are
some problems with the use of HA as a coating
material, such as change in the microstructure of the
coating and a very slow osseointegration rate that
jeopardizes the long-term stability of implants in bony
tissues.5 It has been established that BG has good
mechanical properties and a higher bioactivity in
comparison to HA.5,6 Consequently, the material has
become a natural choice for coating on metallic
implants. Comparative studies between HA coated
and BG coated implants in vivo are scant with
conflicting results.6,7 Therefore, the present study was
undertaken to evaluate and compare the in vivo
behaviour of the BG coated and HA coated (control)
titanium dental implant in the human jaw bone.
MATERIALS AND METHODS
The study was carried out at the Department of
Periodontics, Dr R Ahmed Dental College and Hospi-
tal, Kolkata, India in association with the Bioceramic
and Coating Division of the Central Glass and Ceramic
Research Institute, Kolkata, India. It was approved by
the institutional ethical committee of Dr R Ahmed
Dental College and Hospital, Kolkata, India. Indige-
nous bioactive glass [BG: silica (SiO2) = 43–44 wt.%,
decahydrated borax (Na2B4O7.10H2O) = 6–7 wt.%,
dry soda ash (Na2CO3) = 11–12 wt.%, calcium
carbonate (CaCO3) = 29–30 wt.%, di-ammonium
hydrogen orthophosphate (NH4)2HPO4 = 8–9 wt.%,
68 ª 2011 Australian Dental Association
Australian Dental Journal
The official journal of the Australian Dental Association
titanium oxide (TiO2)=1–2 wt.%] and hydroxyapatite
[HA: derived from calcium hydroxide and phosphoric
acid using coprecipitation technique] that was prepared
(Central Glass and Ceramic Research Institute, Kolk-
ata, India) and characterized earlier, was also used in
the present study.6,8 Titanium alloy (Ti-6Al-4V)
implants (4 mm diameter x 13 mm of length) and
coating on titanium (Ti) dental implants (coating
thickness 70–90 lm) were fabricated in the laboratory
(Central Glass and Ceramic Research Institute, Kolk-
ata, India). HA coating was applied on the implant
surface by air microplasma spray technique, using a
tabletop microplasma spraying machine (Spraymet,
Bangalore, India). BG coating was applied on the
implant surface by conventional vitreous enamelling
technique at 800–810 C in an ambient atmosphere.
Each component of Ti-6Al-4V dental implants was
ultrasonically cleaned and sterilized by gamma radia-
tion after packing.
Thirty-one systemically healthy, partially edentulous
patients (19 males and 12 females, age range 18–
56 years, mean age 36 years) were selected for this
study. Sixty-two implants (31 HA coated Ti-6Al-3V
and 31 BG coated Ti-6Al-3V implants) were placed.
Twenty-eight implants were placed in the anterior
maxilla and 34 implants were placed in the anterior
mandible. Written consent was obtained from all
patients. The period of implant survival was divided
into four stages: Stage I (time between surgical place-
ment and surgical uncovering), Stage II (at the point of
surgical uncovering), Stage III (time between surgical
uncovering and occlusal loading) and Stage IV (time
after occlusal loading of implant).
Patients’ medical and dental history, clinical exam-
ination, oral hygiene habits, anatomic acceptability,
and inclusion and exclusion criteria were thoroughly
assessed before admission to the study.9 Each patient
received at least two implants of the same diameter and
length and of different surface properties (i.e. HA
coated + BG coated) in different but identical sites of
the particular arch. A panoramic radiograph (OPG)
was taken to evaluate the available bone and possible
pathologic conditions before implantation. Magnifica-
tion of the OPG could have been corrected by taking a
radiograph with a metallic mesh of known gap (1 mm x
1 mm) adapted over the jaws. An acrylic copy of the
planned prosthesis was made, which was perforated to
act as a surgical template during the surgical phases.
Alveolar ridge width was evaluated using a No. 15
endodontic file with a rubber stopper upon penetrating
the soft tissues under local anaesthesia and representing
the measured values over a presectioned stone cast. The
implant was used to replace a single tooth by implant
supported artificial crown or multiple teeth by implant
supported fixed bridge that were retained with cement
temporarily over implant abutment throughout the
study period. None of the implants were splinted to
adjacent natural teeth. The permanent restorations
were removed during evaluation visits and permanently
cemented after completion of the study.10
Phase I therapy and oral hygiene instructions were
completed at least one month prior to surgery. Two-
stage surgery was performed for implant placement
(Stage 1 surgery) and exposure of head (Stage 2 surgery)
at three-month intervals in aseptic conditions.9
Standard surgical procedures of implant surgery were
followed.11 After extraoral and intraoral disinfection
and local anaesthesia application, crestal incisions were
made 1.5 mm short of the gingival margin of the
adjacent teeth that was modified at both ends, extend-
ing labially and lingually within the confines of the
attached gingiva. Full thickness flaps were elevated both
labially and lingually to expose the top of the alveolar
ridge. A low speed, high torque (850–1250 rpm, 20–50
Ncm) drilling system (i.e. physio-dispenser) with copi-
ous normal saline irrigation was used to minimize
excessive heat generation and trauma to the bone. A
surgical template or stent was placed on the occlusal
table of the same arch to direct accurate placement of
the implant. A 2.5 mm diameter drill bit (Uniti system,
Equinox, Holland) was used to penetrate at least
3–4 mm of crestal bone for all the osteotomy sites.
The stent was then removed, and the faciolingual and
mesiodistal dimensions of the osteotomy sites were
checked by inserting similar diameter guide pins.
Keeping the guide pins inserted in the other sites, the
same drill bit was used to establish the required depth
(i.e. 14 mm for 13 mm implant) of osteotomy sites one
by one to ensure accurate parallelism of the two
prepared sites. Holes were drilled 1 mm in addition to
implant length to ensure the level of implant was at or
just below the level of crestal bone as all two-staged
osseointegrated implant systems confirm early post-
operative crestal bone loss as a result of surgery.
Progressively larger diameter drill bits (sequential
drilling procedure) were used (i.e. 4 mm for 4 mm
implant). All the drilling procedures were accomplished
with a steady hand, without wobbling, to minimize
funnelling of the coronal portion of the osteotomy sites.
Implants were threaded into place without touching its
surface, at the level of bone using a hand wrench.
Almost all the implants achieved primary stability at
the time of placement. After placement, a healing cover
screw was threaded over the implants and tension free
primary flap closure was obtained to ensure complete
sealing of wound edges to prevent saliva contamination
and maintain a sterile environment around the implant.
Patients were given topical (0.2% chlorhexidine twice
daily x 14 days) and oral antimicrobials (500 mg
amoxycillin thrice daily x 7 days), analgesic medica-
tions (400 mg ibuprofen thrice daily x 3 days with
antacids) and routine post-surgical instructions before
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release from the clinic. Two weeks after Stage 1
surgery, the sutures were removed and the patients
were instructed to gently brush the area with an ultra
soft bristle toothbrush. Stage 2 surgery was performed
to expose implant heads under local anaesthesia and a
gingival healing cuff was screwed into the implant body
to facilitate gingival healing around it. Similar to Stage
1 surgery, routine post-surgical instructions and med-
ications were given to the patients. After two weeks of
Stage 2 surgery, gingiva former was unscrewed and the
abutment screw was screwed into the implant to receive
temporary prosthesis. Patients were then recalled after
one week to receive permanent restoration. From the
date of prosthetic attachment (baseline), patients were
evaluated for one year at six-monthly intervals. The
clinical parameters were recorded to the nearest
millimetre with the help of a University of North
Carolina (UNC-15) probe (Hu-Friedy Inc., Chicago,
USA) for each implant site. The implant-soft tissue
interface was evaluated by plaque index (PI), gingival
index (GI), probing pocket depth (PPD) and gingival
recession (GR). All the clinical parameters were mea-
sured at the following positions: mesial, distal, labial
and lingual (palatal). The highest score of PI, GI, PPD
and GR for each implant was used to determine the
respective score of that implant in a particular visit.
The implant-hard tissue interface was evaluated by
measurement of marginal bone loss by intraoral
periapical (IOPA) x-ray. Measurements taken directly
and ⁄or from the radiographs at implant uncovering
were used as the baseline for radiographs taken at
subsequent follow-up evaluations (Fig 1B). In deter-
mining actual bone loss, radiographic measurements of
bone level were calibrated using a divider and caliper
with 1 ⁄10 mm gradation. Formulas used for calibration
of actual average bone loss of each implant appear in
Fig 2.
Axial CT scan view was also used to evaluate the
implant interface for detection of any possible gap
persisting between the surrounding bone and implant
A B
DC
Fig 1. IOPA x-ray at immediate postoperative period (A), baseline (B), six months (C) and 12 months (D) after permanent prosthetic attachment.
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surface.12 Considering the high radiation exposure, a
single sitting CT scan consisting of one scout view and
two or three axial slices were taken for evaluation. CT
scan view was taken six months after prosthetic loading
in 10 patients of both groups in the maxilla and
mandible (Fig 3). A specific multi-detector spiral CT
scan (MDCT) unit (GE Hi-Speed, GE Health Care,
Boston, USA) was used to evaluate the interface gap for
all patients with 1.5x magnification.
Success ⁄ failure criteria
For the one year follow-up period, a successful
implant was considered to be one that met the
success ⁄ failure criteria. An implant was considered as
failed if one or more of the following conditions were
identified: clinical mobility (>1 mm), unresolved
chronic pain, implant loss, radiolucency around
implant, unresolved infection with the use of antibi-
otics or local treatment which had recurred more than
three times, and marginal bone loss no greater than
one-third of the height of the implant.9,13 Failures of
implants were documented as implant location, type
of implant, stage of treatment at removal and reason
for removal.
Statistical analysis was employed to compare the
study results using a software programme (SPSS
Version 11, SPSS Inc., Chicago, USA). To determine
differences between the coated titanium implants, study
results were analysed using paired samples; t-test for
intra-group comparison, and ANOVA and post hoc test
for inter-group comparison. For each outcome mea-
surement, at least 95% confidence limit was estimated.
No analytical comparison was performed between the
maxilla and mandible. The implantation sites were
divided into two groups: Group I [(control) ) osteot-
omy sites received HA coated Ti implants] and Group II
[osteotomy sites received BG coated Ti implants].
RESULTS
The coated implants of each group (BG and HA) were
fabricated under identical conditions in order to
minimize any experimental error. HA coating was
applied by air microplasma spraying technique which
enables minimum structural change in composition
as compared to conventional air plasma spray. The
in vitro studies of these coatings were reported
earlier.6,8,14
It was found that healing was in general uneventful
for all groups. There was almost no sign of infection or
untoward allergic and foreign-body type of reactions
postoperatively among the samples studied. All the
implants achieved primary stability at the time of Stage
1 surgery except two. The results of the different
clinical and radiological parameters evaluated through-
out the study period are presented in Tables 1–3 and
Figs 1, 3 and 4. Evidence of suppuration, resorption of
almost entire areas of HA coating was observed with
one HA coated implant in the lower jaw at Stage I. But
coating resorption or suppuration was not observed
with any BG coated implants at Stage I failure,
although partial resorption was observed with one
failed BG coated implant at Stage III. Among the
implant types, the implant failure rates of the maxilla
and mandible are shown in Table 3.
Fig 2. Formula used for calibration of actual average marginal bone
loss of each implant.
A B
Fig 3. Interfacial gap around a HA coated implant at axial CT scan view in (A) maxilla and (B) mandible.
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DISCUSSION
This study was a short term, bi-centre, prospective
clinical study with an identified control (HA coated
Ti-6Al-4V dental implant). The study design permitted
comparison of HA coated and BG coated Ti-6Al-4V
dental implant in each subject. To facilitate compari-
son, location of implant, bone quality type and area
basis load distribution to intraoral forces were kept
very much near to identical. Also, all patients did not
receive any long-span fixed prosthesis or combined
implant-tooth supported prosthesis. These types of
studies prevent bias in evaluating clinical success. The
present study has not focused on prosthesis failure but
on the success of implants themselves supporting the
prosthesis. No significant changes were observed with
mean PI, mean GI, mean PPD and mean GR scores
throughout the study period for both coated types in
the upper and lower arches (Tables 1 and 2). This
finding was similar to the observations of Jeffcoat et al.9
who suggested that a low level of plaque did not
interfere with the healing processes of any particular
group. Low GI scores suggested that all the coating
materials were biocompatible, non-toxic, did not elicit
any inflammatory and ⁄or foreign body responses to the
tissues. There was also no apparent retardation of
normal bone healing processes around implants that
claimed to be primary requisites for osseointegration.15
PPD alone might have limited value in providing any
comparable results because it might be changed with
alteration in the position of the gingival margin.16
Crestal and peri-implant bone levels could be best
determined by regular accurate radiographic evalua-
tion.17 The mean average marginal bone loss (ABL) of
the two groups from baseline to 12 months after
prosthetic attachment showed higher values in the
upper arch than the lower arch (Table 1). This might be
due to poorer bone quality in the anterior maxillary
region.18 Statistically significant ABL was found only in
the interval between implant uncovering and six
Table 1. Mean and standard deviation values of Group I (HA) and Group II (BG) at specific time intervals in both
jaws for PI, GI, PPD, ABL and GR. Interfacial gap around implants (CT view) of both jaws at six months also
presented
Parameters HA group (Group I, control) Bioactive glass group (Group II)
Maxilla Baseline 6 months 12 months Baseline 6 months 12 months
PI 0.83 ± 0.40 0.92 ± 0.30 0.82 ± 0.40 0.85 ± 0.36 0.93 ± 0.26 0.78 ± 0.42
GI 0.53 ± 0.52 0.36 ± 0.50 0.27 ± 0.46 0.52 ± 0.51 0.43 ± 0.51 0.21 ± 0.43
PPD (mm) 3.25 ± 0.50 3.50 ± 0.58 3.25 ± 0.50 3.30 ± 0.52 3.50 ± 0.55 3.17 ± 0.40
ABL (mm) 1.13 ± 0.17 1.83 ± 0.10 1.92 ± 0.10 1.12 ± 0.17 1.77 ± 0.18 1.81 ± 0.15
GR (mm) 0.09 ± 0.30 0.18 ± 0.40 0.18 ± 0.40 0.00 ± 0.00 0.11 ± 0.33 0.22 ± 0.44
Interfacial gap in CT scan – 3 implants – – 1 implant –
Mandible
PI 0.80 ± 0.40 0.92 ± 0.30 0.81 ± 0.41 0.78 ± 0.44 0.89 ± 0.33 0.67 ± 0.50
GI 0.56 ± 0.52 0.38 ± 0.50 0.27 ± 0.46 0.52 ± 0.51 0.44 ± 0.51 0.25 ± 0.43
PPD (mm) 3.00 ± 0.00 2.86 ± 0.38 2.71 ± 0.48 3.00 ± 0.00 2.75 ± 0.46 2.62 ± 0.52
ABL (mm) 1.09 ± 0.12 1.69 ± 0.09 1.73 ± 0.09 1.06 ± 0.12 1.56 ± 0.09 1.60 ± 0.09
GR (mm) 0.09 ± 0.30 0.18 ± 0.40 0.18 ± 0.40 0.07 ± 0.26 0.21 ± 0.42 0.21 ± 0.42
Interfacial gap in CT scan – 1 implant – – 1 implant –
PI = plaque index; GI = gingival index; PPD = probing pocket depth; ABL = average marginal bone loss; GR = gingival recession.
A B
Fig 4. IOPA x-ray of failed HA coated and BG coated implants from mandibular sites at Stage I.
72 ª 2011 Australian Dental Association
S Mistry et al.
months after prosthetic loading for the two groups in
both jaws (Table 2), apparently due to the initial load
application on healing implants compared to the
unloaded condition.18 Changes of mean ABL values
from baseline to 12 months after prosthetic attachment
in both upper and lower jaws were less for the BG
coated group (Table 2) compared to the HA group,
which suggests that the osteostimulatory property of
bioactive glass might change the remodelling responses
of bone.19 All the values of mean bone level changes
observed in the present study were in the direction of
bone loss, although bone gain around different types of
implants would certainly be possible.18
Evaluation of bone-implant interface around the
metallic implant with CT scan was documented
previously.12 An increased number of interfacial gaps
(IFG) (four) in the anterior maxilla were found
(Table 1, Fig 3) compared to the anterior mandible
(two), and suggests that more rapid and mature bone
formation resulted in greater bone to implant body
contact in the anterior mandible.20 Least IFG with BG
coated implants indicated early implant stabilization
and load bearing capacity in poor quality bone
compared to HA group, as also observed by Ghosh
et al. in animal models.6 However, gaps shown in the
CT scan view were not true gaps because radiodensity
in all IFG regions were greater than 400 Hounsfield
units. It suggests that immature osteoid containing
interface regions are likely to appear as radiolucent
gaps, although simultaneous use of CT scan and
Table 3. Number of failures in Group I and Group II in maxilla and mandible at different time intervals
Parameters HA group (Group I, control) Bioactive glass group (Group II)
Maxilla total-28 implants Stage I Stage II Stage III Stage IV Stage I Stage II Stage III Stage IV
No. of failure 1 – – 1 – – 1 –
Failure rate 14.28%
(of 14 implants)
7.14%
(of 14 implants)
Mandible total-34 implants
No. of failure 2 – – – 1 – – –
Failure rate 11.76%
(of 17 implants)
5.88%
(of 17 implants)
Table 2. Paired t-values (intra-group comparisons) and results of inter-group comparisons (ANOVA and post hoc
test) of Group I and Group II at baseline, six months and 12 months after prosthetic attachment in both jaws for PI,
GI, PPD, ABL and GR
Parameters HA group (Group I, control) Bioactive glass group (Group II) Inter-group
comparison
Maxilla
Baseline to
6 months
(paired t-value)
6 months to
12 months
(paired t-value)
Baseline to
12 months
(paired t-value)
Baseline to
6 months
(paired t-value)
6 months to
12 months
(paired t-value)
Baseline to
12 months
(paired t-value)
ANOVA and
post hoc test
PI )0.55
p > 0.05
0.55
p > 0.05
0.50
p > 0.05
)0.56
p > 0.05
1.00
p > 0.05
0.56
p > 0.05
p > 0.05 NS
GI 0.80
p > 0.05
0.43
p > 0.05
1.93
p > 0.05
0.36
p > 0.05
1.14
p > 0.05
1.75
p > 0.05
p > 0.05 NS
PPD )1.00
p > 0.05
1.00
p > 0.05
0.00
p > 0.05
)1.00
p > 0.05
1.58
p > 0.05
1.00
p > 0.05
p > 0.05 NS
ABL )9.89
p < 0.05
0.00
p > 0.05
)11.31
p < 0.05
)19.03
p < 0.05
)2.24
p > 0.05
)15.65
p < 0.05
p > 0.05 NS
GR )1.00
p > 0.05
0.00
p > 0.05
)1.00
p > 0.05
)1.47
p > 0.05
0.00
p > 0.05
)1.47
p > 0.05
p > 0.05 NS
Mandible
PI )0.55
p > 0.05
0.55
p > 0.05
0.58
p > 0.05
)0.56
p > 0.05
1.00
p > 0.05
0.56
p > 0.05
p > 0.05
NS
GI 0.78
p > 0.05
0.46
p > 0.05
1.90
p > 0.05
0.35
p > 0.05
1.16
p > 0.05
1.76
p > 0.05
p > 0.05 NS
PPD 1.00
p > 0.05
1.00
p > 0.05
1.55
p > 0.05
1.53
p > 0.05
1.00
p > 0.05
2.05
p > 0.05
p > 0.05 NS
ABL )13.74
p < 0.05
)2.12
p > 0.05
)12.17
p < 0.05
)26.45
p < 0.05
)2.05
p > 0.05
)29.37
p < 0.05
p > 0.05 NS
GR )1.00
p > 0.05
0.00
p > 0.05
)1.00
p > 0.05
)1.47
p > 0.05
0.00
p > 0.05
)1.47
p > 0.05
p > 0.05 NS
NS = not significant; GR = gingival recession; PI = plaque index; ABL = average marginal bone loss; PPD = probing pocket depth; GI = gingival
index.
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histological analysis in an animal model may eventually
elucidate the actual aetiology of such interface radio-
lucency.
One HA coated implant failed (Table 3) at Stage I,
which might be due to encroachment of the incisive
canal by the implant during surgical placement that
resulted in a proliferation of entrapped epithelium
(peri-implant radiolucency).21 One HA coated implant
also failed at Stage IV in the maxilla (Table 3) due to
increased mobility as a consequence of intraoral load
but the BG coated implant was firmly fixed to bone on
the other side of the restoration. In the upper jaw, one
BG coated implant failed at Stage III due to increased
mobility. Therefore, the chances of failure were less
with BG coated implant types in poor quality bone
compared to HA coated implants in both non-loaded
and loaded condition. In the lower jaw, one of each
coated implant type failed at Stage I (Fig 4B), probably
due to the reduced ability of high density alveolar bone
(anterior mandible) to cope with inaccurate surgical
technique. Evidence of suppuration and almost entire
resorption of HA coating after surgical removal was
observed with one HA coated implant in the lower jaw
at Stage I, possibly due to the resorption of HA coating
at the local acidic environment in abscessed osteotomy
sites.22 Absence of suppuration and intact BG coating
on a failed implant in the lower jaw demonstrated that
BG produce an alkaline medium around the implant
through dissolution of alkali ions that might prevent
coating resorption upon failure. The antimicrobial
properties of BG might also have some role in
preventing infection.23 Among the implant types, the
implant failure rates of BG coated implants were less
than HA coated implants in both arches (Table 3). For
implant failure occurring at Stage I, the rate of failure
was increased as bone density increased. For implant
failure discovered in Stage III and Stage IV, the rate of
failure was increased as bone density decreased.
CONCLUSIONS
A total of 62 implants in 31 patients were investigated,
of which six implants failed and the rest were successful.
Overall results showed that BG coated implants are as
equally successful as HA coated implants in achieving
osseointegration and to support final restorations under
the present experimental conditions. Equally important
was the fact that it did not cause extra biological
complications and therefore is safe to be used in
humans. As the sample size of the present study is
small, further similar studies are required to throw more
light on the observations made in this study and to come
to a definite conclusion. The comparative evaluation of
the in vivo performance of coating on metallic dental
implants (HA coating by microplasma technique and
BG coating by enamelling technique) in the human body
is in agreement with the in vitro evaluation and
comparative animal study results reported earlier.
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